Disc Medicine
+5
Jan 20, 2026
•
6 min read
2025 Funding numbers are in, 2026 early raises, Lyra Therapeutics runs out of time and more
Journal Club
+1
Jan 13, 2026
5 min read
Evaluating the potential impact of off-target degradation of KT-474
Kestrel Therapeutics
+13
Jan 6, 2026
8 min read
Neumora's positive clinical data , new tenants at the Arsenal, and more
Empress Therapeutics
+6
Dec 16, 2025
A Multi-Million dollar public offering, the developing race for a dupilumab alternative, business awards, and more.
Portal Biotechnologies
Dec 9, 2025
Plus, How to design a PROTAC
+10
Dec 2, 2025
Stratus Therapeutics winding down, Consider the ALS TDI for Giving Tuesday, and more
Enanta Pharmaceuticals
+16
Nov 18, 2025
Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more
+7
Nov 11, 2025
Talking about proteases, PROTACs, and molecular glues. Plus new methods for mass spec tagging, viral inhibitors, and more.
+12
Nov 4, 2025
Soufflé Therapeutics Launches from Stealth, Disc and Werewolf receive FDA priority, Affini-T may be winding down.
